Loading…

Investigation of the Odilorhabdin Biosynthetic Gene Cluster Using NRPS Engineering

The recently identified natural product NOSO‐95A from entomopathogenic Xenorhabdus bacteria, derived from a biosynthetic gene cluster (BGC) encoding a non‐ribosomal peptide synthetase (NRPS), was the first member of the odilorhabdin class of antibiotics. This class exhibits broad‐spectrum antibiotic...

Full description

Saved in:
Bibliographic Details
Published in:Angewandte Chemie 2024-08, Vol.136 (33), p.n/a
Main Authors: Präve, Leonard, Seyfert, Carsten E., Bozhüyük, Kenan A. J., Racine, Emilie, Müller, Rolf, Bode, Helge B.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The recently identified natural product NOSO‐95A from entomopathogenic Xenorhabdus bacteria, derived from a biosynthetic gene cluster (BGC) encoding a non‐ribosomal peptide synthetase (NRPS), was the first member of the odilorhabdin class of antibiotics. This class exhibits broad‐spectrum antibiotic activity and inspired the development of the synthetic derivative NOSO‐502, which holds potential as a new clinical drug by breaking antibiotic resistance. While the mode of action of odilorhabdins was broadly investigated, their biosynthesis pathway remained poorly understood. Here we describe the heterologous production of NOSO‐95A in Escherichia coli after refactoring the complete BGC. Since the production titer was low, NRPS engineering was applied to uncover the underlying biosynthetic principles. For this, modules of the odilorhabdin NRPS fused to other synthetases were co‐expressed with candidate hydroxylases encoded in the BGC allowing the characterization of the biosynthesis of three unusual amino acids and leading to the identification of a prodrug‐activation mechanism by deacylation. Our work demonstrates the application of NRPS engineering as a blueprint to mechanistically elucidate large or toxic NRPS and provides the basis to generate novel odilorhabdin analogues with improved properties in the future. The biosynthesis of the odilorhabdin biosynthetic gene cluster (BGC) was elucidated by engineering of the central non‐ribosomal peptide synthetase (NRPS). Therefore, specific modules of the odilorhabdin synthetase were assembled to well‐studied NRPS systems, which resulted in small and non‐toxic NRPS test systems. This method enabled an in vivo investigation of the biosynthesis of targeted NRPS modules and accessory genes of the BGC in E. coli.
ISSN:0044-8249
1521-3757
DOI:10.1002/ange.202406389